Surmodics (SRDX)
(Delayed Data from NSDQ)
$39.26 USD
-0.14 (-0.36%)
Updated Sep 20, 2024 03:59 PM ET
After-Market: $39.27 +0.01 (0.03%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth D Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
SRDX 39.26 -0.14(-0.36%)
Will SRDX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SRDX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SRDX
SurModics (SRDX) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Down -5.46% in 4 Weeks, Here's Why SurModics (SRDX) Looks Ripe for a Turnaround
SRDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
SurModics (SRDX) Loses -6.29% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Here's What Key Metrics Tell Us About SurModics (SRDX) Q3 Earnings
SurModics (SRDX) Reports Q3 Loss, Tops Revenue Estimates
Other News for SRDX
Beryl Capital Management LLC Acquires New Stake in Revance Therapeutics Inc
Beryl Capital Management LLC Acquires New Stake in Seaport Entertainment Group Inc
Top Merger Stocks Held By Fund Managers, Mid-Q3 2024
Hold Rating Maintained Amid SurModics Acquisition Delays and FTC Scrutiny
Surmodics merger deal draws FTC second request